Policy & Regulation

Budget 2026: India Just Allocated ₹1.06 Lakh Crore to Healthcare — Here Is What Every Founder Must Know

By BHC, Editor in Chief · March 31, 2026 · 5 min read

BHC, Editor in Chief — Budget 2026: India Just Allocated ₹1.06 Lakh Crore to Healthcare — Here Is What Every Founder Must Know

Summary

  • India's Union Budget 2026-27 allocates ₹1.06 lakh crore to healthcare — the highest ever. This complete breakdown covers what matters most for healthcare founders, hospital operators, and investors.

India's Union Budget 2026-27 has delivered the country's highest-ever healthcare allocation: ₹1,06,530 crore to the Ministry of Health & Family Welfare — a 10% increase over the previous year, constituting 2% of the overall budget. For healthcare founders, hospital operators, and investors, this is not just a headline number. Buried within the allocation are specific programmes, missions, and structural reforms that will directly shape the commercial healthcare landscape for the next five years.

"The Budget reflects a quiet but consequential shift — from viewing healthcare as social infrastructure to recognising it as strategic national capability."

Here is a complete breakdown of what matters and why.

**The Numbers That Matter

The Department of Health and Family Welfare received ₹1,01,709 crore — a 9% increase. The Department of Health Research received ₹4,821 crore — a 23% increase. ICMR's allocation jumped by nearly 27% to ₹4,000 crore, the largest increase in the research body's recent history. The National Health Mission received ₹39,390 crore (up 6%). Mental health programme allocation rose 14% to approximately ₹51 crore. AB-PMJAY and ABDM both received significantly enhanced allocations in line with the government's push to reduce out-of-pocket expenditure and expand digital health infrastructure.

**The Biopharma Shakti Mission

The single most commercially significant announcement in Budget 2026 for the healthcare sector is the ₹10,000 crore Biopharma Shakti mission, committed over five years. This mission is designed to position India as a global biopharma innovation hub — funding domestic R&D, biosimilar development, clinical validation, and manufacturing scale-up. For founders and investors in biopharma and life sciences, this is a direct funding opportunity. For hospitals and health systems, it signals a pipeline of domestically developed biologics and biosimilars that will improve treatment access and reduce costs.

**Medical Value Tourism and Global Positioning

Budget 2026 outlines the establishment of five Medical Value Tourism hubs across India, developed in partnership with state governments and the private sector. This is a strategic move: India already attracts patients from Southeast Asia, Africa, and the Middle East for complex procedures at significantly lower cost than Western countries. Formalising and investing in medical tourism infrastructure will accelerate this — creating demand for internationally accredited hospitals, specialised clinical teams, and supporting services.

**AI Governance and Technology

The Budget announces a high-powered panel to assess the impact of artificial intelligence on the services sector — including healthcare. The framing here is important: the government is signalling that AI regulation in healthcare will be proactive, not reactive. For health-tech founders building AI diagnostic tools, clinical decision support systems, or AI-enabled administrative platforms, this creates both opportunity and regulatory responsibility. Those who engage with the governance process early will be better positioned.

**Tax and Investment Environment

Budget 2026 creates a more predictable and compliance-efficient tax environment for biopharma, MedTech, and healthcare manufacturing. Customs duty exemptions on select cancer drugs have been extended. These measures improve affordability for patients while encouraging innovation and domestic manufacturing investment.

**BHC Perspective

At Bengaluru Health Community, we see Budget 2026 as a genuine policy tailwind for the healthcare ecosystem. The combination of record spending, targeted missions like Biopharma Shakti, and structural reforms in digital health and AI governance creates a more favourable environment for healthcare founders than we have seen in years. The challenge — always — is execution. Bengaluru is well-placed to capture a disproportionate share of this opportunity, given its concentration of health-tech talent, research institutions, and clinical infrastructure. We will be publishing a detailed analysis of how BHC's ecosystem can benefit from each of these Budget commitments in the weeks ahead.

**Frequently Asked Questions

Q: What is the total healthcare allocation in Budget 2026?
A: The Union Budget 2026-27 allocated ₹1,06,530 crore to the Ministry of Health & Family Welfare — a 10% increase over the previous year and the highest ever healthcare allocation in India's history.

Q: What is the Biopharma Shakti mission?
A: The Biopharma Shakti mission is a ₹10,000 crore initiative over five years, designed to position India as a global biopharma innovation hub by funding domestic R&D, biosimilar development, and manufacturing scale-up.

Q: How does Budget 2026 affect healthcare startups?
A: Budget 2026 benefits healthcare startups through increased research funding, the Biopharma Shakti mission, Medical Value Tourism hub investments, AI governance frameworks, and a more predictable tax environment for MedTech and biopharma companies.